Intellia Therapeutics Inc 最大收入来源是 Genome Editing-based Therapies,在最近的收益报告中收入为 57,877,000。就地区而言, United States 是 Intellia Therapeutics Inc 的主要市场,收入为 57,877,000。
Metal Arts Company Inc 是否盈利?
不,根据最新的财务报表,Intellia Therapeutics Inc 的净损失为 $-412
Metal Arts Company Inc 有负债吗?
是的,Intellia Therapeutics Inc 的负债为 170
Metal Arts Company Inc 的流通股有多少?
Intellia Therapeutics Inc 的总流通股为 116.31
关键数据
前收盘价
$0.0005
开盘价
$0.0003
当日区间
$0.0003 - $0.0005
52周范围
$0.0001 - $0.013
交易量
16.0K
平均成交量
31
股息收益率
--
每股收益(TTM)
--
市值
$6.4K
什么是 MTRT?
Metal Arts Co., Inc. engages in providing blockchain core technology in South Korea. The company is headquartered in New York City, New York. The Company’s core processor is MxP (Medium eXPress engine). The firm provides high speed performance networks to support a range of business-to-business (B2B) and business-to-customer (B2C) services including finance (DeFi, digital asset custody), games, social virtual reality (VR), digital contents, entertainment, and others.